APA   Click to copy
Darguzyte, M., Rama, E., Rix, A., Baier, J., Hermann, J., Rezvantalab, S., … Kiessling, F. (2024). Riboflavin-targeted polymers improve tolerance of paclitaxel while maintaining therapeutic efficacy. Nanomedicine: Nanotechnology, Biology and Medicine, 58. https://doi.org/10.1016

Chicago/Turabian   Click to copy
Darguzyte, Milita, Elena Rama, Anne Rix, Jasmin Baier, Juliane Hermann, Sima Rezvantalab, Mohammad Khedri, Joachim Jankowski, and Fabian Kiessling. “Riboflavin-Targeted Polymers Improve Tolerance of Paclitaxel While Maintaining Therapeutic Efficacy.” Nanomedicine: Nanotechnology, Biology and Medicine 58 (2024).

MLA   Click to copy
Darguzyte, Milita, et al. “Riboflavin-Targeted Polymers Improve Tolerance of Paclitaxel While Maintaining Therapeutic Efficacy.” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 58, ISSN 1549-9634, j.nano.2024.102751. (https://www.sciencedirect.com/science/article/pii/S1549963424000200, 2024, doi:10.1016.

@article{milita2024a,
  title = {Riboflavin-targeted polymers improve tolerance of paclitaxel while maintaining therapeutic efficacy},
  year = {2024},
  journal = {Nanomedicine: Nanotechnology, Biology and Medicine},
  volume = {58},
  doi = {10.1016},
  author = {Darguzyte, Milita and Rama, Elena and Rix, Anne and Baier, Jasmin and Hermann, Juliane and Rezvantalab, Sima and Khedri, Mohammad and Jankowski, Joachim and Kiessling, Fabian},
  howpublished = {ISSN 1549-9634, j.nano.2024.102751. (https://www.sciencedirect.com/science/article/pii/S1549963424000200}
}